Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
Massive Bio, Inc. is seeking a commercially minded sales professional to own the full sales cycle for Pharma Commercial and Real World Data solutions, including the Nexus Pulse platform.
You will engage with pharma decision-makers to open doors and drive multi-stakeholder agreements, leveraging relationships in Medical Affairs and Commercial teams. Ideal candidates have 1–3 years of pharma sales experience, oncology familiarity is a plus, and comfort working in an entrepreneurial environment.
Every cancer patient deserves access to treatment options. Massive Bio is an AI-powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating the barriers of geography, financial constraints, and information asymmetry that have historically limited enrollment.
Founded in 2015 and headquartered in US, Massive Bio is scaling its impact globally by powering operations across multiple countries and bringing innovative cancer treatment options to a rapidly growing and diverse population of patients. Through our proprietary AI platform, we connect individuals to clinical trials worldwide and partner with leading pharmaceutical companies, contract research organizations (CROs), and healthcare systems to accelerate drug development and expand equitable access to cutting-edge therapies.
Massive Bio's pharma offerings span the full journey from clinical development to in-market performance, across Clinical, Commercial, and Real World Data solutions. This role owns commercial growth of our Pharma Commercial and Real World Data portfolio, including the Nexus Pulse platform, with leading pharmaceutical companies in oncology. You will own the full sales cycle from first conversation to signed agreement, working closely with company leadership throughout.
We are looking for someone who sells, or has sold, pharma commercial and real-world data solutions and can open doors with the right stakeholders from day one.